| (-)-ERYTHROMYCIN |
| (2R,3S,4S,5R,6R,8R,10R,11R,12S,13R)-5-(3-amino-3,4,6-trideoxy-N,N-dimethyl--D-xylo-hexopyranosyloxy)-3-(2,6-dideoxy-3-C,3-O-dimethyl--L-ribo-hexopyranosyloxy)-13-ethyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethyl-9-oxotridecan |
| (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxa |
| (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4 |
| (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9 |
| (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7, |
| (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyc |
| (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyc |
| (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]ox |
| (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyr |
| (3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3- |
| 114-07-8 |
| 114E078 |
| 374700-25-1 |
| 44496-EP2272846A1 |
| 44496-EP2275422A1 |
| 44496-EP2292608A1 |
| 44496-EP2305644A1 |
| 44496-EP2308866A1 |
| 44496-EP2311814A1 |
| 44496-EP2311828A1 |
| 44496-EP2380568A1 |
| 63937KV33D |
| 82343-12-2 |
| 9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
| A/T/S |
| AB00051981_09 |
| AB00051981_10 |
| Abboticin |
| Abomacetin |
| AC-12744 |
| AC-12901 |
| AC1L1ZUR |
| Acneryne |
| Acnesol |
| ACT03320 |
| adecane-2,10-dione (non-preferred name) |
| AI3-50138 |
| Ak-Mycin |
| Akne Cordes Losung |
| Akne-Mycin |
| Akne-mycin (TN) |
| Aknederm Ery Gel |
| Aknemycin |
| Aknin |
| AKOS015895249 |
| AustriaS |
| BB_NC-1332 |
| BC205124 |
| BDBM50344942 |
| Benzamycin |
| Benzamycin Pak |
| BIDD:GT0017 |
| BPBio1_000312 |
| BSPBio_000282 |
| BSPBio_002480 |
| C-23475 |
| C-Solve-2 |
| C01912 |
| CA006619 |
| CA006620 |
| CAS-114-07-8 |
| CC-27517 |
| CCG-38992 |
| CCRIS 9078 |
| CHEBI:42355 |
| CHEMBL3735423 |
| CHEMBL532 |
| CPD000544946 |
| CS-2168 |
| D00140 |
| D02YIZ |
| DB00199 |
| Del-Mycin |
| Derimer |
| Deripil |
| DivK1c_000294 |
| DivK1c_000397 |
| DivK1c_000702 |
| Dotycin |
| DR003518 |
| DSSTox_CID_2991 |
| DSSTox_GSID_22991 |
| DSSTox_RID_76820 |
| DTXSID4022991 |
| Dumotrycin |
| E-3250 |
| E-Base |
| E-Base (base) |
| E-Glades |
| E-Mycin |
| E-Mycin (base) |
| E-mycin, Erycin, Robimysin |
| E-mycin, Erythrocin |
| E-Solve 2 |
| E0751 |
| EC 204-040-1 |
| EINECS 204-040-1 |
| EM-A |
| Emgel |
| Emu-V |
| Emu-Ve |
| Emuvin |
| Emycin |
| Endoeritrin |
| Erecin |
| Erimycin-T |
| Erisone |
| Eritomicina |
| Eritrocina |
| Eritromicina |
| Eritromicina [INN-Spanish] |
| Ermycin |
| Eros |
| erthromycin |
| ERY |
| Ery-B |
| Ery-Diolan |
| Ery-maxin |
| Ery-Sol |
| Ery-Tab |
| Ery-Tab (base) |
| Eryacne |
| Eryacnen |
| ERYC |
| ERYC (base) |
| Eryc (TN) |
| Eryc 125 |
| Eryc-125 |
| Eryc-250 |
| Erycen |
| Erycette |
| Erycin |
| Erycinum |
| Eryderm |
| Erydermer |
| Erygel |
| Erygel (TN) |
| Eryhexal |
| Erymax |
| Erymed |
| Erysafe |
| Erytab |
| Erythra-Derm |
| erythro |
| Erythro-Statin |
| Erythro-Teva |
| Erythrocin |
| Erythrocin stearate |
| Erythroderm |
| Erythrogran |
| Erythroguent |
| Erythromast 36 |
| Erythromid |
| erythromycin |
| Erythromycin (JP15/USP/INN) |
| Erythromycin (JP17/USP/INN) |
| Erythromycin (mixture A,B,C) |
| Erythromycin [INN:BAN:JAN] |
| Erythromycin [USP:INN:BAN:JAN] |
| Erythromycin & VRC3375 |
| Erythromycin A |
| Erythromycin A, B + C |
| Erythromycin A, European Pharmacopoeia (EP) Reference Standard |
| Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279 |
| Erythromycin base |
| ERYTHROMYCIN GLUCEPTATE |
| Erythromycin glucoheptonate |
| Erythromycin intravenous |
| Erythromycin Lactate |
| Erythromycin Ointment |
| Erythromycin sodium lauryl sulfate |
| Erythromycin standard solution, 1 mg/mL in H2O |
| ERYTHROMYCIN STEARATE |
| erythromycin-A |
| ERYTHROMYCIN, [N-METHYL-14C] |
| Erythromycin, Antibiotic for Culture Media Use Only |
| Erythromycin, BioReagent, suitable for cell culture |
| Erythromycin, Biotechnology Performance Certified |
| Erythromycin, compd. with monododecyl sulfate, sodium salt |
| Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard |
| Erythromycin, meets USP testing specifications |
| Erythromycin, N-demethyl-N-(methyl-11C)- |
| Erythromycin, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Erythromycin, plant cell culture tested, ~98% |
| Erythromycin, potency: >=850 mug per mg |
| Erythromycin, tested according to Ph.Eur. |
| Erythromycin, United States Pharmacopeia (USP) Reference Standard |
| Erythromycine |
| Erythromycine [INN-French] |
| Erythromycines |
| Erythromycinum |
| Erythromycinum [INN-Latin] |
| Erytop |
| Erytrociclin |
| GTPL1456 |
| HMS1920M04 |
| HMS2091D05 |
| HMS2095O04 |
| HMS500O16 |
| HSDB 3074 |
| HY-B0220 |
| IDI1_000294 |
| IDI1_000397 |
| IDI1_000702 |
| Ilocaps |
| Ilosone (estolate) |
| Iloticina |
| Ilotycin |
| Ilotycin gluceptate |
| Ilotycin T.S |
| Ilotycin T.S. |
| Inderm |
| Inderm Gel |
| IndermRetcin |
| KBio1_000294 |
| KBio1_000397 |
| KBio1_000702 |
| KBio2_000555 |
| KBio2_001139 |
| KBio2_003123 |
| KBio2_003707 |
| KBio2_005691 |
| KBio2_006275 |
| KBioGR_001175 |
| KBioSS_000555 |
| KBioSS_001139 |
| Kesso-Mycin |
| Latotryd |
| Lederpax |
| LMPK04000006 |
| LS-187077 |
| MCULE-4566208867 |
| Mephamycin |
| Mercina |
| MFCD00084654 |
| MLS001066618 |
| MolPort-002-507-378 |
| N-Methylerythromycin A |
| NCGC00094670-01 |
| NCGC00179619-01 |
| NCGC00179619-02 |
| NCGC00179619-03 |
| NCGC00254234-01 |
| NCI-C55674 |
| NINDS_000294 |
| NINDS_000397 |
| NINDS_000702 |
| NSC 55929 |
| NSC-756759 |
| NSC55929 |
| NSC756759 |
| Oftalmolosa Cusi Eritromicina |
| Oftamolets |
| Paediathrocin |
| Pantoderm |
| Pantodrin |
| Pantomicina |
| Pce (TN) |
| PCE Dispertab (base) |
| Pfizer-E |
| Pharmakon1600-01500280 |
| Pharyngocin |
| Prestwick_205 |
| Prestwick3_000151 |
| Primacine |
| Propiocine |
| Proterytrin |
| R-P Mycin |
| Retcin |
| Robimycin |
| Romycin |
| SAM002643510 |
| Sans-acne |
| Sansac |
| SBI-0051368.P003 |
| SC-13736 |
| SCHEMBL2601 |
| Sentry AQ mardel maracyn |
| Skid Gel E |
| SMP1_000119 |
| SMR000544946 |
| SPBio_000778 |
| SPBio_001226 |
| Spectrum_000115 |
| Spectrum_000659 |
| SPECTRUM1500280 |
| Spectrum2_000759 |
| Spectrum2_001263 |
| Spectrum4_000538 |
| Spectrum5_001596 |
| SR-01000799155 |
| SR-01000799155-2 |
| Staticin (TN) |
| Stiemicyn |
| Stiemycin |
| Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin |
| T-Stat |
| T-stat (TN) |
| Taimoxin-F |
| Theramycin Z |
| Tiloryth |
| Tiprocin |
| Torlamicina |
| Tox21_111311 |
| Tox21_111869 |
| Tox21_300515 |
| Udima Ery Gel |
| ULGZDMOVFRHVEP-RWJQBGPGSA-N |
| UNII-63937KV33D |
| Wemid |
| Wyamycin S |
| ZINC85534336 |
| ZX-AFC000696 |
